The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether liraglutide, a drug approved and widely used in
the treatment of type 2 diabetes, has an effect on bone mass and bone cell function. Type 2
diabetes may cause multiple complications, and it is well known that patients with type 2
diabetes have a higher risk of fractures. If Liraglutide can be demonstrated to have a
positive effect on bone, this may be one among other factors to consider before the decision
about specific treatment of type 2 diabetes is made for the individual patient.